Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study
- PMID: 29763593
- PMCID: PMC6231996
- DOI: 10.1016/j.jalz.2018.03.011
Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study
Abstract
Introduction: The interplay between midlife vascular risk factors and midlife cognitive function with later life mild cognitive impairment (MCI) and dementia (DEM) is not well understood.
Methods: In the Atherosclerosis Risk in Communities Study, cardiovascular risk factors and cognition were assessed in midlife, ages 45-64 years. In 2011-2013, 20-25 years later, all consenting Atherosclerosis Risk in Communities participants underwent a cognitive and neurological evaluation and were given adjudicated diagnoses of cognitively normal, MCI, or DEM.
Results: In 5995 participants with complete covariate data, midlife diabetes, hypertension, obesity, and hypercholesterolemia were associated with late-life MCI and DEM. Low midlife cognition function was also associated with greater likelihood of late-life MCI or DEM. Both midlife vascular risk factors and midlife cognitive function remained associated with later life MCI or DEM when both were in the model.
Discussion: Later life MCI and DEM were independently associated with midlife vascular risk factors and midlife cognition.
Keywords: APOE; Cognition; Dementia; Diabetes; Epidemiology; Hypertension; Mild cognitive impairment; Prevalence.
Copyright © 2018 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Association of Midlife Plasma Amyloid-β Levels With Cognitive Impairment in Late Life: The ARIC Neurocognitive Study.Neurology. 2021 Sep 14;97(11):e1123-e1131. doi: 10.1212/WNL.0000000000012482. Epub 2021 Aug 4. Neurology. 2021. PMID: 34349010 Free PMC article.
-
Correlates of Dementia and Mild Cognitive Impairment in Patients With Atrial Fibrillation: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).J Am Heart Assoc. 2017 Jul 24;6(7):e006014. doi: 10.1161/JAHA.117.006014. J Am Heart Assoc. 2017. PMID: 28739861 Free PMC article.
-
Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.JAMA Neurol. 2017 Oct 1;74(10):1246-1254. doi: 10.1001/jamaneurol.2017.1658. JAMA Neurol. 2017. PMID: 28783817 Free PMC article.
-
Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study.Curr Alzheimer Res. 2013 Jun;10(5):549-55. doi: 10.2174/1567205011310050011. Curr Alzheimer Res. 2013. PMID: 23566344 Clinical Trial.
-
Classification and epidemiology of MCI.Clin Geriatr Med. 2013 Nov;29(4):753-72. doi: 10.1016/j.cger.2013.07.003. Clin Geriatr Med. 2013. PMID: 24094295 Free PMC article. Review.
Cited by
-
Childhood obesity and risk of Alzheimer's disease: a Mendelian randomization study.Arch Public Health. 2024 Mar 18;82(1):39. doi: 10.1186/s13690-024-01271-y. Arch Public Health. 2024. PMID: 38500220 Free PMC article.
-
Personality and cognitive errors in the Healthy Aging in Neighborhoods of Diversity across the Life Span study.J Res Pers. 2024 Apr;109:104449. doi: 10.1016/j.jrp.2023.104449. Epub 2023 Dec 15. J Res Pers. 2024. PMID: 38312326
-
Epigenetic age acceleration as a biomarker for impaired cognitive abilities in adulthood following early life adversity and psychiatric disorders.Neurobiol Stress. 2023 Oct 15;27:100577. doi: 10.1016/j.ynstr.2023.100577. eCollection 2023 Nov. Neurobiol Stress. 2023. PMID: 37885906 Free PMC article.
-
Effect of cognitive reserve on the association between slow wave sleep and cognition in community-dwelling older adults.Aging (Albany NY). 2023 Sep 28;15(18):9275-9292. doi: 10.18632/aging.204943. Epub 2023 Sep 28. Aging (Albany NY). 2023. PMID: 37770186 Free PMC article. Clinical Trial.
-
Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.J Alzheimers Dis. 2023;94(1):101-113. doi: 10.3233/JAD-220931. J Alzheimers Dis. 2023. PMID: 37212094 Free PMC article.
References
-
- Amieva H, Le Goff M, Millet X, Orgogozo JM, Peres K, Barberger-Gateau P, et al. Prodromal Alzheimer’s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64(5):492–8. - PubMed
-
- Elias MF, Beiser A, Wolf PA, Au R, White RF, D’Agostino RB. The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham cohort. Arch Neurol. 2000;57(6):808–13. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 HL096812/HL/NHLBI NIH HHS/United States
- U01 HL096917/HL/NHLBI NIH HHS/United States
- U01 HL096902/HL/NHLBI NIH HHS/United States
- HHSN268201700002C/HL/NHLBI NIH HHS/United States
- HHSN268201700001I/HL/NHLBI NIH HHS/United States
- HHSN268201700004I/HL/NHLBI NIH HHS/United States
- U01 HL096814/HL/NHLBI NIH HHS/United States
- HHSN268201000021C/HL/NHLBI NIH HHS/United States
- R01 HL070825/HL/NHLBI NIH HHS/United States
- HHSN268201700021C/HL/NHLBI NIH HHS/United States
- HHSN268201700003I/HL/NHLBI NIH HHS/United States
- HHSN268201700005C/HL/NHLBI NIH HHS/United States
- HHSN268201700001C/HL/NHLBI NIH HHS/United States
- HHSN268201700003C/HL/NHLBI NIH HHS/United States
- U01 HL096899/HL/NHLBI NIH HHS/United States
- HHSN268201700004C/HL/NHLBI NIH HHS/United States
- K24 AG052573/AG/NIA NIH HHS/United States
- HHSN268201700002I/HL/NHLBI NIH HHS/United States
- HHSN268201700005I/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
